{"id":"https://openalex.org/W4245107010","doi":"https://doi.org/10.7326/0003-4819-122-8-199504150-00001","title":"The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy","display_name":"The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy","publication_year":1995,"publication_date":"1995-04-15","ids":{"openalex":"https://openalex.org/W4245107010","doi":"https://doi.org/10.7326/0003-4819-122-8-199504150-00001","pmid":"https://pubmed.ncbi.nlm.nih.gov/7887548"},"language":"en","primary_location":{"id":"doi:10.7326/0003-4819-122-8-199504150-00001","doi":"https://doi.org/10.7326/0003-4819-122-8-199504150-00001","is_oa":false,"landing_page_url":"https://doi.org/10.7326/0003-4819-122-8-199504150-00001","pdf_url":null,"source":{"id":"https://openalex.org/S119722071","display_name":"Annals of Internal Medicine","issn_l":"0003-4819","issn":["0003-4819","1539-3704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316812","host_organization_name":"American College of Physicians","host_organization_lineage":["https://openalex.org/P4310316812"],"host_organization_lineage_names":["American College of Physicians"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Internal Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"The Diabetes Control and Complications Trial Research Group.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"The Diabetes Control and Complications Trial Research Group.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":8.1134,"has_fulltext":false,"cited_by_count":606,"citation_normalized_percentile":{"value":0.983992,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"122","issue":"8","first_page":"561","last_page":"568"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intensive-diabetes-therapy","display_name":"intensive diabetes therapy","score":0.8059999942779541},{"id":"https://openalex.org/keywords/diabetic-neuropathy","display_name":"diabetic neuropathy","score":0.9179999828338623},{"id":"https://openalex.org/keywords/diabetic-polyneuropathy","display_name":"diabetic polyneuropathy","score":0.9190000295639038},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.9670000076293945},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9520000219345093},{"id":"https://openalex.org/keywords/continuous-subcutaneous-insulin-infusion","display_name":"insulin pump therapy","score":0.8989999890327454},{"id":"https://openalex.org/keywords/multiple-daily-injections","display_name":"multiple daily insulin injections","score":0.9490000009536743},{"id":"https://openalex.org/keywords/nerve-conduction-velocity","display_name":"nerve conduction velocity","score":0.7170000076293945},{"id":"https://openalex.org/keywords/autonomic-dysfunction","display_name":"autonomic dysfunction","score":0.8289999961853027},{"id":"https://openalex.org/keywords/neuropathy-prevention","display_name":"neuropathy prevention","score":0.6470000147819519},{"id":"https://openalex.org/keywords/diabetes-control-and-complications-trial","display_name":"Diabetes Control and Complications Trial","score":0.8199999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9687227010726929},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.668443500995636},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.645694375038147},{"id":"https://openalex.org/C2778313320","wikidata":"https://www.wikidata.org/wiki/Q550455","display_name":"Retinopathy","level":3,"score":0.5857788324356079},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5144403576850891},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4870465099811554},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4490787982940674},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4388201832771301},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42597153782844543},{"id":"https://openalex.org/C2779178840","wikidata":"https://www.wikidata.org/wiki/Q2046550","display_name":"Diabetic neuropathy","level":3,"score":0.4199706017971039},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.35735023021698},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.17227420210838318}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003929","descriptor_name":"Diabetic Neuropathies","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003929","descriptor_name":"Diabetic Neuropathies","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003929","descriptor_name":"Diabetic Neuropathies","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007260","descriptor_name":"Infusion Pumps","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007332","descriptor_name":"Insulin Infusion Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009431","descriptor_name":"Neural Conduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.7326/0003-4819-122-8-199504150-00001","doi":"https://doi.org/10.7326/0003-4819-122-8-199504150-00001","is_oa":false,"landing_page_url":"https://doi.org/10.7326/0003-4819-122-8-199504150-00001","pdf_url":null,"source":{"id":"https://openalex.org/S119722071","display_name":"Annals of Internal Medicine","issn_l":"0003-4819","issn":["0003-4819","1539-3704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316812","host_organization_name":"American College of Physicians","host_organization_lineage":["https://openalex.org/P4310316812"],"host_organization_lineage_names":["American College of Physicians"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Internal Medicine","raw_type":"journal-article"},{"id":"pmid:7887548","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7887548","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of internal medicine","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2887886667","https://openalex.org/W4416644250","https://openalex.org/W1994691784","https://openalex.org/W2156593233","https://openalex.org/W2750149697","https://openalex.org/W2024599259","https://openalex.org/W4231879574","https://openalex.org/W2113796602","https://openalex.org/W2010740931","https://openalex.org/W52391068"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"examine":[2],"whether":[3],"intensive":[4,192,233,251,276],"therapy":[5,28,108,133,143,193,201,277,287],"designed":[6],"to":[7,13,60,73,91,97,178,221,227],"achieve":[8],"glycemic":[9],"levels":[10],"as":[11,15,152,299],"close":[12],"normal":[14],"possible":[16],"prevents":[17,291],"or":[18,111,116,124,136,155,168,290],"slows":[19],"the":[20,36,145,181,191,199,232,244,250,264,292],"progression":[21],"of":[22,63,147,187,190,198,205,231,243,249,263,294],"neuropathy":[23,150,161],"when":[24],"compared":[25,130,195,240,260],"with":[26,31,109,131,134,159,196,241,261,275,281,308],"conventional":[27,132,200,245,265,282],"in":[29,35,180,306],"patients":[30,57,307],"insulin-dependent":[32,68,309],"diabetes":[33,69,88,286,310],"mellitus":[34,70],"Diabetes":[37],"Control":[38],"and":[39,51,76,94,209,223],"Complications":[40],"Trial.":[41],"DESIGN:":[42],"Multicenter,":[43],"randomized,":[44],"controlled":[45],"clinical":[46,53,149,160],"trial.":[47],"SETTING:":[48],"29":[49],"U.S.":[50],"Canadian":[52],"centers.":[54],"PARTICIPANTS:":[55],"1441":[56],"aged":[58],"13":[59],"39":[61],"years,":[62],"whom":[64],"726":[65],"had":[66,67,77,86,87,95,254],"for":[71,89],"1":[72,90],"5":[74,185],"years":[75,93,186],"no":[78],"retinopathy":[79,100],"at":[80,101],"baseline":[81,102],"(primary":[82],"prevention":[83],"cohort);":[84],"715":[85],"15":[92],"minimal":[96],"moderate":[98],"nonproliferative":[99],"(secondary":[103],"intervention":[104],"cohort).":[105],"INTERVENTION:":[106],"Intensive":[107,142,285],"three":[110],"more":[112,125],"daily":[113,138],"insulin":[114,119,139],"injections":[115],"continuous":[117],"subcutaneous":[118],"infusion":[120],"guided":[121],"by":[122,163,173,217,301],"four":[123],"glucose":[126],"tests":[127],"per":[128],"day":[129],"one":[135],"two":[137],"injections.":[140],"RESULTS:":[141],"reduced":[144,216],"development":[146,293],"confirmed":[148,162,300],"(defined":[151],"a":[153],"history":[154],"physical":[156],"examination":[157],"consistent":[158],"either":[164],"abnormal":[165,206,210,237,255],"nerve":[166,207,238,269,303],"conduction":[167,208,239,270],"autonomic":[169,211,256],"nervous":[170,212,257],"system":[171,213,258],"testing)":[172],"64%":[174],"(95%":[175],"CI,":[176],"45%":[177],"76%)":[179],"combined":[182],"cohorts":[183],"after":[184],"follow-up":[188],"(5%":[189],"group":[194,235,253],"13%":[197],"group).":[202,267],"The":[203],"prevalence":[204],"function":[214,259,304],"were":[215],"44%":[218],"(CI,":[219,225],"34%":[220],"53%)":[222],"53%":[224],"24%":[226],"70%),":[228],"respectively":[229],"(26%":[230],"treatment":[234,246,252,266],"developed":[236],"46%":[242],"group;":[247],"4%":[248],"9%":[262],"Finally,":[268],"velocities":[271],"generally":[272],"remained":[273],"stable":[274],"but":[278],"decreased":[279],"significantly":[280],"therapy.":[283],"CONCLUSION:":[284],"markedly":[288],"delays":[289],"clinically":[295],"manifest":[296],"diabetic":[297],"polyneuropathy":[298],"objective":[302],"testing":[305],"mellitus.":[311]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":22},{"year":2021,"cited_by_count":19},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":22},{"year":2017,"cited_by_count":22},{"year":2016,"cited_by_count":25},{"year":2015,"cited_by_count":19},{"year":2014,"cited_by_count":25},{"year":2013,"cited_by_count":23},{"year":2012,"cited_by_count":24}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2022-05-12T00:00:00"}